SCOR SE (SCRYY)
OTHER OTC:SCRYY
Want to see SCRYY full AI Analyst Report?
Top Page
SCOR SE
(OTC:SCRYY)
Select Model
Select Model
Rating:62Neutral
Price Target:
$3.50
▲(6.06% Upside)
Action:Reiterated
Date:06/05/26
The score is driven primarily by solid financial quality (especially consistent free cash flow and reasonable leverage) and attractive valuation (low P/E and high dividend yield). These positives are offset by weak technical momentum and the fundamental risk of declining revenue and uneven profitability.
Positive Factors
Cash Generation
Consistent positive operating and free cash flow gives SCOR durable internal funding to support claims, reserve builds and dividends without frequent capital raises. Reliable cash conversion cushions underwriting cycles and preserves financial flexibility over the medium term.
Negative Factors
Declining Revenue
Three consecutive years of top-line decline, including a steep fall in 2025, indicate shrinking underwriting scale or lost business. Persistent revenue contraction undermines economies of scale, reduces premium diversification, and constrains medium-term growth prospects.
Read all positive and negative factors
Positive Factors
Negative Factors
Cash Generation
Consistent positive operating and free cash flow gives SCOR durable internal funding to support claims, reserve builds and dividends without frequent capital raises. Reliable cash conversion cushions underwriting cycles and preserves financial flexibility over the medium term.
Read all positive factors
SCOR SE (SCRYY) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$6.23B
Dividend Yield5.81%
Average Volume (3M)121.00
Price to Earnings (P/E)6.2
Beta (1Y)0.77
Revenue Growth2.07%
EPS GrowthN/A
CountryUS
Employees3,621
SectorFinancial
Sector Strength70
IndustryInsurance - Reinsurance
Share Statistics
EPS (TTM)0.35
Shares Outstanding1,793,899,800
10 Day Avg. Volume0
30 Day Avg. Volume121
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)11.62
Price to Sales (P/S)3.30
P/FCF Ratio52.86
Enterprise Value/Market Cap1.16
Enterprise Value/Revenue0.46
Enterprise Value/Gross Profit0.46
Enterprise Value/Ebitda1.68
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.5
Revenue Forecast (FY)$18.47B
SCOR SE Business Overview & Revenue Model
Company Description
SCOR SE functions as a prominent global reinsurance provider, offering a comprehensive suite of life and non-life protection solutions. The company boasts a broad international footprint, serving clients across Europe, the Middle East, Africa, the...
How the Company Makes Money
SCOR makes money primarily by underwriting reinsurance and investing the capital ("float") generated from its insurance operations.
1) Reinsurance underwriting revenue (core business)
- Property & Casualty (P&C) reinsurance: SCOR assumes a portio...
SCOR SE Earnings Call Summary
Earnings Call Date:Mar 04, 2026
(Q4-2025)
| % Change Since: |
Next Earnings Date:Jul 30, 2026
Earnings Call Sentiment Positive
The call was predominantly positive: SCOR reported record net income, robust ROE, strong solvency (215%), significant economic value growth (+13.7% vs 9% target), a raised dividend (+5.6%), EUR 170m of cost savings ahead of plan, excellent P&C underwriting metrics (combined ratio well below target, nat cat and attritional loss ratios improving), and Life & Health and investment results beating guidance. Key risks and headwinds were noted but appear manageable: competitive P&C pricing and SBS weakness, some underperforming Life contracts (addressed with reserve strengthening), refinancing timing on Tier 2, man-made loss volatility, pending arbitration, and potential Solvency II reform impacts (estimated -10–15ppt). Overall, the positive operational and capital outcomes materially outweigh the identified lowlights.Positive Updates
Record Full-Year Net Income
Net income for FY2025 was EUR 846 million, the highest in SCOR's history, supported by strong contributions from P&C, Life & Health and Investments.
Negative Updates
P&C Revenue Pressure and SBS Weakness
P&C insurance revenue down 1.6% in Q4 at constant FX; on a full-year basis, adjusted insurance revenue was flat with reinsurance up 2% but SBS down 4%, reflecting softness in some segments.
Read all updates
Q4-2025 Updates
Positive
Negative
Record Full-Year Net Income
Net income for FY2025 was EUR 846 million, the highest in SCOR's history, supported by strong contributions from P&C, Life & Health and Investments.
Read all positive updates
Company Guidance
SCOR reiterated confidence in delivering its Forward ’26 targets, guiding to a P&C combined ratio below 87% in 2026 (nat‑cat budget ~10%; Q4 nat‑cat 7.6%, YTD 6.8%; Q4 attritional loss ratio 74.7%, YTD 76.4%), continued opportunistic buffer building (already above the initial €300m target), and net‑net operating capital generation of 3–5 percentage points of solvency ratio in 2026; key metrics cited include group solvency ratio 215% (up 5 pts vs 2024), economic value +13.7% at constant economics (EV/share €48), financial leverage 25.3% (from 24.5%), proposed dividend €1.90/share (+5.6% vs €1.80) setting a new floor, FY net income €846m and ROE 19.1% (Q4 net income €214m, Q4 annualized ROE 21.1%), Life & Health new business CSM FY €464m (Q4 €170m) and insurance service result FY €450m (Q4 €115m) vs ~€0.4bn target, P&C new business CSM +9% FY, investments RoIA 3.6% in Q4 with investment income €209m and regular yield 3.8%, management savings €170m achieved (costs flat vs 2023) and expense‑ratio guidance 7–8% (2025: 7.4%).SCOR SE Financial Statement Overview
Summary
Income Statement
58
Neutral
Balance Sheet
64
Positive
Cash Flow
71
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 15.57B | 15.65B | 15.84B | 16.44B | 15.99B |
| Gross Profit | 15.57B | 14.83B | 15.16B | 12.61B | 12.11B |
| EBITDA | 0.00 | 520.00M | 1.58B | -1.32B | 1.23B |
| Net Income | 817.41M | 4.00M | 812.00M | -1.38B | 456.00M |
Balance Sheet | |||||
| Total Assets | 36.08B | 37.35B | 35.61B | 34.70B | 47.52B |
| Cash, Cash Equivalents and Short-Term Investments | 2.08B | 2.39B | 1.86B | 1.81B | 2.09B |
| Total Debt | 3.43B | 3.45B | 3.23B | 3.24B | 3.17B |
| Total Liabilities | 31.66B | 32.82B | 30.87B | 30.38B | 41.10B |
| Stockholders Equity | 4.43B | 4.52B | 4.71B | 4.28B | 6.40B |
Cash Flow | |||||
| Free Cash Flow | 973.02M | 875.00M | 1.45B | 430.00M | 2.32B |
| Operating Cash Flow | 1.01B | 903.00M | 1.48B | 500.00M | 2.41B |
| Investing Cash Flow | -848.15M | -181.00M | -954.00M | -269.00M | -1.54B |
| Financing Cash Flow | -347.71M | -213.00M | -428.00M | -567.00M | -674.00M |
SCOR SE Technical Analysis
Neutral
3.30
Price Trends
3.60
Negative
3.44
Positive
3.31
Positive
Market Momentum
-0.03
Positive
39.46
Neutral
7.96
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SCRYY, the sentiment is Neutral. The current price of 3.3 is below the 20-day moving average (MA) of 3.64, below the 50-day MA of 3.60, and below the 200-day MA of 3.31, indicating a neutral trend. The MACD of -0.03 indicates Positive momentum. The RSI at 39.46 is Neutral, neither overbought nor oversold. The STOCH value of 7.96 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for SCRYY.
SCOR SE Peers Comparison
UnderperformOutperform
Sector (68)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | $13.10B | 6.55 | 13.31% | 2.37% | -0.63% | 147.66% | |
77 Outperform | $3.03B | 4.92 | 23.38% | ― | 20.32% | 98.92% | |
75 Outperform | $13.18B | 10.85 | 9.47% | 1.76% | 18.66% | 55.67% | |
74 Outperform | $12.03B | 4.27 | 24.71% | 0.57% | -8.19% | 90.81% | |
73 Outperform | $2.57B | 5.10 | 22.02% | ― | 22.94% | 317.95% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
62 Neutral | $6.23B | 6.16 | 20.03% | 5.81% | 2.07% | ― |
* Financial Sector Average
SCRYY
SCOR SE
3.48
0.34
10.90%
EG
Everest Group
330.93
0.78
0.24%
RGA
Reinsurance Group
201.21
2.13
1.07%
RNR
Renaissancere Holdings
282.11
40.29
16.66%
SPNT
SiriusPoint
21.85
2.54
13.15%
HG
Hamilton Insurance Group, Ltd. Class B
30.51
10.93
55.84%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.